Loading...
NPI 1003812082 · Chesapeake, VA · Physical Medicine & Rehabilitation Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Beth Winke is a physical medicine & rehabilitation physician provider located in Chesapeake, Virginia. This profile covers 17 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Beth Winke |
| Address | 808 Eden Way N Ste 102 |
| City | Chesapeake |
| State | VA |
| ZIP | 23320 |
| Taxonomy | Physical Medicine & Rehabilitation Physician |
| NPI Enumerated | June 23, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $903.5K |
| Medicaid | $93.2K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
17 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1,930 | $190 | $360.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,640 | $90 | $224.2K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 2,180 | $60 | $130.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,360 | $60 | $83.1K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 150 | $240 | $34.8K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 150 | $150 | $23.3K |
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 100 | $210 | $20.9K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 110 | $110 | $12.1K |
| 97813 | The provider uses solid, metallic, fine, single–use needles to pierce the skin and stimulate anatomical points on or in the skin by manipulating the needles by electrical stimulation for an initial… | 110 | $30 | $3.7K |
| 27096 | The provider performs an injection in the joint between the sacrum and ilium on one side of the body, with the aid of imaging equipment to locate the injection site. He injects an anesthetic to… | 20 | $150 | $3.1K |
Showing 1–10 of 17
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
17 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| G0482 | 2 | 10 | 60 | $190 | $80.8K |
| G0483 | 3 | 10 | 110 | $240 | $67.6K |
| J3300 | 7 | 10 | 3,080 | $1 | $63.1K |
| 64483 | 77 | 170 | 80 | $210 | $31.4K |
| G0481 | 5 | 10 | 120 | $150 | $27.8K |
| 80307 | 1 | 40 | 80 | $60 | $21.7K |
| 99214 | 9 | 12,890 | 140 | $80 | $21K |
| 99213 | 78 | 12,440 | 90 | $60 | $10K |
| 27096 | 111 | 130 | 40 | $140 | $9.9K |
| 20610 | 747 | 1,160 | 60 | $50 | $6.1K |
Showing 1–10 of 17
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 330 | $120 | $40.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 540 | $60 | $30K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 380 | $50 | $18.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 130 | $40 | $4.7K |
How this provider's Medicaid billing volume and revenue compare to other Virginia providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Virginia median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 13 | 20 | 1,220 | $110 | $459.9K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 136 | 170 | 3,790 | $40 | $415.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,596 | 3,520 | 370 | $70 | $280.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 2,589 | 4,010 | 290 | $50 | $199.8K |
Other providers in the same ZIP code as Beth Winke, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Chesapeake Hospital Authority | VA | General Acute Care Hospital | $0 | $45.6M |
| Hnh Virginia, Inc. | VA | Home Health Agency | $0 | $42.9M |
| Gateway Services, LLC | VA | Community/Behavioral Health Agency | $0 | $39.8M |
| Sentara Enterprises | VA | Home Infusion Agency | $0 | $38.7M |
| City Of Chesapeake | VA | Community/Behavioral Health Agency | $0 | $27.4M |
| Clients First Home Health Inc. | VA | Home Health Agency | $0 | $24.8M |
| Immanual Care | VA | Home Health Agency | $0 | $23M |
| Y Christian Care LLC | VA | Home Health Agency | $0 | $18.7M |
| Sentara Enterprises | VA | Home Health Agency | $0 | $12.5M |
| Renaissance Counseling Services, LLC | VA | Community/Behavioral Health Agency | $0 | $10.8M |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.